Researchers at the Children’s Cancer Institute have discovered a combination of therapies that appear highly effective at combatting neuroblastoma and other forms of aggressive childhood cancer.
An international research team has developed a new algorithm based on blood and cerebrospinal fluid biomarker measurements for the diagnostics of dementia.
Drs Kei Kanie and Ryuji Kato from Nagoya University are trying to break open the data-driven cell culture process development concept to ensure that the future of cell manufacturing will promise quality cell therapy products.